FDA WEIGHS PART 11 OVERHAUL, TURNS TO INDUSTRY FOR SUGGESTIONS

Washington Drug Letter
KEYWORDS FDA / Part 11
A A

Seeking to make Part 11 "less prescriptive," the FDA is calling on industry for advice as the agency considers whether to revise the rule or issue additional guidance documents.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00